Company: PGEN
Filing Date: 2025-04-28
Form Type: 10-K/A
Source: 0001356090-25-000011
Chunk: 25

Company: PRECIGEN, INC.
Filing Date: 2025-04-28
Form: 10-K/A
Chunk 25
---
 Harry Thomasian Jr. |     |                            |  40 | % |     | $                            |   195,200 |     |    |     | 110%                  |     | $                    | — |     |         |   154,475 |     | $              |   214,720 |
| Donald P. Lehr      |     |                            |  40 | % |     | $                            |   230,000 |     |    |     | 100%                  |     | $                    | — |     |         |   165,468 |     | $              |   230,000 |
| Rutul R. Shah       |     |                            |  40 | % |     | $                            |   194,000 |     |    |     | 125%                  |     | $                    | — |     |         |   174,460 |     | $              |   242,500 |
| Phil Tennant        |     |                            |  40 | % |     | $                            |    90,542 |     | -1 |     | 102%                  |     | $                    | — |     |         |    66,441 |     | $              |    92,353 |

______________________________________________________________________________________________________

(1) Represents Mr. Tennant’s target bonus prorated from his employment start date to the end of the year. His annualized target bonus (without proration) was $204,000.

#### Long-Term Equity Incentive Awards
Our primary objectives in granting long-term equity incentive awards are to encourage significant ownership of our common stock by management and to provide long-term financial incentives linked directly to our long-term performance. The Compensation Committee believes that significant ownership of our common stock by senior management helps to align the interests of management and the shareholders. After taking into account the overall position of the Company during the year, the Compensation Committee made grants of long-term incentive awards to its executives for 2024 as noted below.

In May 2024, the Compensation Committee approved grants of stock options to Dr. Sabzevari and Messrs. Thomasian, Lehr, Shah, and Perez, each of which vests as to one-fourth of the award one year after the date of grant, with the balance of the award vesting in 36 successive equal monthly installments thereafter.

In connection with the commencement of Mr. Tennant’s employment in July 2024 and pursuant to